University Hospitals Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
NCT Number: NCT01537458
Tricuspid valve insufficiency (TI) is often noted on echocardiography. Although severe TI is known to cause significant morbidity and mortality, no good guidelines are available to guide intervention. Literature is mostly confined to tricuspid valve repair concomitant with mitral valve repair. Treatment options for isolated repair have not been investigated thoroughly.
The investigators want to evaluate retrospectively the outcome of isolated tricuspid valve repair, performed in our center. By doing this, the investigators want to evaluate predictors of outcome after repair.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Leuven, Vlaams-Brabant, 3000, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
follow-up of patients that underwent TV repair in the past.
Time frame: 10 year
Time frame: 10 year
Time frame: 10 year
Time frame: 10 year
Time frame: 10 year
hospitalisation for cardiovascular reasons
Time frame: 10 years
Universitaire Ziekenhuizen KU Leuven
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04522154
Cardiovascular Diseases, Heart Diseases
Bad Oeynhausen, North Rhine-Westphalia, Germany
View Trial DetailsNCT03227757
Cardiovascular Diseases, Heart Diseases
Los Angeles, California, United States
View Trial DetailsNCT03775759
Cardiovascular Diseases, Heart Diseases
Durham, North Carolina, United States
View Trial DetailsNCT01444222
Cardiovascular Diseases, Heart Diseases
Leuven, Vlaams-Brabant, Belgium
View Trial Details